Clinicopathologic correlations in lupus nephritis in Lima, Peru

Nephron

Volumn 83, Issue 4, 1999, Pages 323-330

  Hurtado, Abdias ^a   Asato, Carmen ^b   Escudero, Elizabeth ^a   Stromquist, Chris S ^c   Urcia, Jaime ^a   Hurtado, Maria Elena ^a   De La Cruz, Sonia ^b   Wener, Mark H ^d   Zavala, Rodolfo ^a   Johnson, Richard J ^c,e  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b HOSPITAL NACIONAL GUILLERMO ALMENARA IRIGOYEN   (Peru)

^c Division of Nephrology   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Activity, chronicity indices; Lupus nephritis; Macrophage; Renal pathology; Smooth muscle actin

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 4;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; FEMALE; HEMATURIA; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOLOGY; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; MALE; MESANGIUM CELL; PERU; PRIORITY JOURNAL; PROTEINURIA;

EID: 0032737324     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045424     Document Type: Article

References (42)

1. Churg J, Sobin LH: Renal Disease: Classification and Atlas of Glomerular Disease. New York, Igaku-Shoin, 1982, pp 127-149.
2. Austin JA, Muenz LR, Joyce KM, Antonovych T, Kullick M, Klippel J, Decker J, Balow J: Prognostic factors in lupus nephritis. Am J Med 1983;75:382-391.
3. Austin HA, Muenz LR, Joyce KM, Antonovych T, Balow J: Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome. Kidney Int 1984;25:689-695.
4. Appel GB, Silva F, Piraani C, Meltzer JI, Estes D: Renal involvement in systemic lupus erythematosus: A survery of 56 patients emphasizing histologic classification. Medicine (Baltimore) 1978;57:371-410.
5. Banfi F, Mazzucco G, Di Belgiojos GB, Bosisio MB, Stratta P, Confalonieri R, Ferrario F, Imbasciati E, Monga G: Morphological parameters in lupus nephritis: Their relevance for classification and relationship with clinical and histological findings and outcome. Q J Med 1985;55:153-168.
6. Leaker B, Fairley KF, Dowling J, Kincaid-Smith P: Lupus nephritis: Clinical and pathological correlation. Q J Med 1987;62:163-179.
7. Shaykul C, Ong-aj-yooth L, Chirawong P, Nimmannit S, Parichatikanond P, Laohapand T, Vasuvattakul S, Vareesangthip K, Vanichakarn S, Malasit P, Nilwarangkur S: Lupus nephritis in Thailand: Clinicopathological findings and outcome in 569 patients. Am J Kidney Dis 1995;26:300-307.
8. Mitjavila F, Pac V, Moga I, Poveda R, Vidaller M, Carrera M, Pujol R: Clinicopathological correlations and prognostic factors in lupus nephritis. Clin Exp Rheumatol 1997;15:625-631.
9. Appel G, Cohen DJ, Pirani CL, Meltzer JI, Estes D: Long-term follow-up of patients with lupus nephritis: A study based on the classification of the World Health Organization. Am J Med 1987;83:877-885.
10. Gladman DD, Urowitz MB, Cole E, Ritchie S, Chang CH, Churg J: Kidney biopsy in SLE. I. A clinical-morphologic evaluation. Q J Med 1989;73:1125-1133.
11. Nossent HC, Henzen-Logmans, Vroom TM, Berden JHM, Swaak TJG: Contribution of renal biopsy data in predicting outcome in lupus nephritis. Arthritis Rheum 1990;33:970-977.
12. Schwartz MM, Bernstein J, Hill GS, Holley K, Phillips EA, Lupus Nephritis Collaborative Study Group: Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Kidney Int 1989;36:891-896.
13. Johnson RJ: The glomerular response to injury: Progression or resolution? Kidney Int 1994;45: 1769-1782.
14. Alpers CE, Hudkins KL, Gown AM, Johnson RJ. Enhanced expression of 'muscle-specific' actin in glomerulonephritis. Kidney Int 1992; 41:1134-1192.
15. MacPherson BR, Leslie KO, Lizasa KV, Schwartz JE: Contractile cells of the kidney in primary glomerular disorders: An immunohistochemical study using an anti-alpha-smooth muscle actin monoclonal antibody. Hum Pathol 1993;24:710-716.
16. Jothy S, Sawka RJ: Presence of monocytes in systemic lupus erythematosus-associated glomerulonephritis. Arch Pathol Lab Med 1981; 105:590-593.
17. Zhang G, Moorhead PJ, El-Nahas AM: Myofibroblasts and the progression of experimental glomeruonephritis. Exp Nephrol 1995;3:308-318.
18. Boukhalfa G, Desmoulière A, Rondeau E, Gabbiani G, Sraer JD: Relationship between alpha-smooth muscle actin expression and fibrotic changes in human kidney. Exp Nephrol 1996;4:241-247.
19. Groma V, Marcussen N, Olsen S: A quantitative immunohistochemical study of the expression of mesangial alpha-smooth muscle actin and the proliferation marker Ki-67 in glomerulonephritis in man. Virchows Arch 1997;431: 345-350.
20. Kobayashi M, Koyama A, Narita M, Shigematsu H: Intraglomerular monocytes in human glomerulonephritis. Nephron 1991;59:580-585.
21. Risdon RA, Sloper JC, De Wardener HE: Relationship between renal function and histologic changes found in renal biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968;ii:363-366.
22. Schainuck LI, Striker GE, Cutler RE, Benditt EP: Structural-functional correlations in renal disease. Hum Pathol 1970;1:631-641.
23. Bohle A, Mackensen-Haen S, Harolo G: Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: A morphometric contribution. Am J Nephrol 1987;7:421-433.
24. Eddy A: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996;7:2495-2508.
25. Johnson RJ, Hugo C, Hasely L, Pichler R, Bassuk J, Thomas S, Suga S, Couser WG, Shankland SJ: Mechanisms of progressive glomerulosclerosis and tubulointerstitial fibrosis. Clin Exp Nephrol 1998;2:308-313.
26. Goumenos DS, Brown CB, Shortland J, El-Nahas AM: Myofibroblasts: Predictors of progession of mesangial IgA nephropathy? Nephrol Dial Transplant 1994;9:1418-1425.
27. Hewitson TD, Becker GJ: Interstitial myofibroblasts in IgA glomerulonephritis. Am J Nephrol 1995;15:111-117.
28. Roberts IS, Burrows C, Shanks JH, Veening M, McWilliam LJ: Interstitial myofibroblasts: Predictors of progression in membranous nephropathy. J Clin Pathol 1997;50:123-127.
29. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277.
30. Wener MH: Circulating immune complexes; in Rose NR, DeMacario EC, Folds JD, Lane HC, Nakamura RM (eds): Manual of Clinical Laboratory Immunology, ed 5. American Society for Microbiology, 1997, pp 208-216.
31. Alpers CE, Hudkins KL, Floege J, Johnson RJ: Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol 1994;5:201-210.
32. Ogata K, Kurki P, Celis JE, Nakamura RM, Tan EM: Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication. Exp Cell Res 1987;168:475-486.
33. Mahajan SK, Ordonez NG, Feitelson PJ, Lim VS, Spargo BH, Katz AI: Lupus nephropathy without clinical renal involvement. Medicine (Baltimore) 1977;56:493-501.
34. Magil A, Puterman ML, Ballon HS, Chan V, Lirenman D, Rae A, Sutton RAL: Prognostic factors in diffuse proliferative lupus glomerulonephritis. Kidney Int 1988;34:511-517.
35. Johnson RJ, Schreiner GF: Hypothesis: The role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension. Kidney Int 1997;52:1169-1179.
36. Mise N, Kimura K, Nagai R, Ohba S, Suzuki N, Miyashita K, Tojo A, Goto A, Omata M: Mesangial expression of a nonmuscle myosin heavy chain, Smemb, is associated with glomerular sclerosis and renal prognosis in IgA nephropathy. Nephron 1998;78:284-289.
37. Magil AB, Cohen AH: Monocytes and focal glomerulosclerosis. Lab Invest 1989;61:404-409.
38. Monga G, Mazzucco G, di Belgiojoso GB, Busnach G: The presence and possible role of monocyte infiltration in human chronic proliferative glomerulonephritides. Am J Pathol 1979;94:271-284.
39. Magil A, Ballon HS, Chan V, Lirenman DS, Rae A, Sutton RAL: Diffuse proliferative lupus glomerulonephritis: Determination of prognostic significance of clinical, laboratory and pathologic factors. Medicine (Baltimore) 1984; 63:210-220.
40. Alexopoulos E, Seron D, Hartley RB, Cameron JS: Lupus nephritis: Correlation of interstitial cells with glomerular function. Kidney Int 1990;37:100-109.
41. Park MH, D'Agati V, Appel GB, Pirani CL: Tubulointerstitial disease in lupus nephritis: Relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. Nephron 1986;44:309-319.
42. Eddy AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 1994;5: 1273-1287.